Key Metrics
  • No. of Employees37
  • Founded Year 2010
  • Company StagePrivate Limited Company
  • Total Funding₹100 Cr
  • Industry

  • Headquarter
  • Company StatusActive
About Symbio Generrics

Symbio Generrics India Private Limited is a specialized Active Pharmaceutical Ingredients (APIs) manufacturing, marketing, and service organization.

Symbio strives to attain long-term commercial excellence for their formulation partners by aligning to their regional and global strategies. They partner with pharmaceuticals, life sciences, biotechnology, agrochemicals, and specialty chemicals companies to deliver active ingredients, intermediates, and R&D services.

Symbio’s manufacturing facilities are situated near Bengaluru and Visakhapatnam. Their core competency lies in the supply of APIs globally. They have a well-established sales and distribution network catering to the leading generic companies in emerging and regulated markets. They believe in supplying the best quality APIs that are adherent to international regulatory, production, and quality control standards.

Business Model

Symbio Generics is a pharmaceutical company that develops, manufactures, and markets generic APIs (Active Pharmaceutical Ingredients) and finished dosages. Symbio engages with potential partners for contract development & manufacturing of advanced intermediates and APIs for emerging and regulated markets.

Top Competitors
SA
Solara Active Pharma SciencesL24230MH2017PLC291636
AD
Aarti DrugsL37060MH1984PLC055433
LL
Laurus LabsL24239AP2005PLC047518
Symbio Generrics Funding Details
Funding Highlights
Latest Funding RoundSeries B
Total Funding Raised₹100 Cr
No. of Investments Made0
Total No. of Acquisitions0
Lead Investors1
Investors
  • Ascent Capital
Funding Details
TheKredible's detailed funding report contains info about Funding raised by the company along with Lead Investors, Investors, Shareholding Strcuture, and its Investments & Acquisitions.
₹799.00 ₹1,598.00
Funding History
TheKredible's 'Funding History' report provides deep insights of Funding with list of Lead Investors
₹399.00 ₹798.00
Funding Per Year
A Funding report of the company's overall funding on yearly basis, segregated by the team TheKredible.
₹199.00 ₹398.00
Symbio Generrics Financial Details
Financial Highlights
FY 2023-24 Revenue₹489.38 Cr
FY 2023-24 Expenses₹467.13 Cr
FY 2023-24 Profit/Loss₹16.12 Cr
Net Cash Flow From Operations-₹5.67 Cr
Full Financial Details
Detailed report containing info about Business Model, year-wise Financial Comparison, Ratio Analysis and detailed Revenue and Expense breakdowns.
₹799.00 ₹1,598.00
Financial Comparison
A detailed report of year-wise Financial Comparison of the company
₹430.00 ₹860.00
Revenue Breakdown
A report and breakdown of the company's year-wise revenue streams.
₹399.00 ₹798.00
Expense Breakdown
A report and breakdown of the company's year-wise expenditures.
₹399.00 ₹798.00
Shareholding Structure
Team at TheKredible has gone through several ROC filings and portrayed Shareholding Structure of the company.
₹499.00 ₹998.00
Financial Ratio
Analysis of Financial Ratios which gives quick insights about the company's profitability and capital efficiency.
₹199.00 ₹398.00
Symbio Generrics Key People
People Metrics
Current Core Team2
Board Members/Directors5

Core Team

AP
Akash Puranik Co-Founder
SS
Salim Shaikh SadiqCo-Founder

Board Members/Directors

SS
Salim Sadiq Shaik Wholetime Director
AS
Akash Suresh Puranik Managing Director
SN
Sharma Natraj KannanDirector
DK
Deepak Komaregowda Nominee Director
AS
Ajay Subhash MittalNominee Director
Symbio Generrics Documents

AY - 2018-19

Profit and Loss statement - Symbio Generrics - 2018-19.pdf
TheKredible's experts has summarized the Profit and Loss Statement of Symbio Generrics for FY 2018-19.
₹249.00 ₹498.00
Balance Sheet - Symbio Generrics - 2018-19.pdf
TheKredible's experts has summarized the Balance Sheet of Symbio Generrics for FY 2018-19.
₹249.00 ₹498.00

AY - 2019-20

Profit and Loss statement - Symbio Generrics - 2019-20.pdf
TheKredible's experts has summarized the Profit and Loss Statement of Symbio Generrics for FY 2019-20.
₹249.00 ₹498.00
Balance Sheet - Symbio Generrics - 2019-20.pdf
TheKredible's experts has summarized the Balance Sheet of Symbio Generrics for FY 2019-20.
₹249.00 ₹498.00

AY - 2020-21

Profit and Loss statement - Symbio Generrics - 2020-21.pdf
TheKredible's experts has summarized the Profit and Loss Statement of Symbio Generrics for FY 2020-21.
₹249.00 ₹498.00
Balance Sheet - Symbio Generrics - 2020-21.pdf
TheKredible's experts has summarized the Balance Sheet of Symbio Generrics for FY 2020-21.
₹249.00 ₹498.00

AY - 2021-22

Profit and Loss statement - Symbio Generrics - 2021-22.pdf
TheKredible's experts has summarized the Profit and Loss Statement of Symbio Generrics for FY 2021-22.
₹249.00 ₹498.00
Balance Sheet - Symbio Generrics - 2021-22.pdf
TheKredible's experts has summarized the Balance Sheet of Symbio Generrics for FY 2021-22.
₹249.00 ₹498.00

AY - 2022-23

Profit and loss statement - Symbio Generrics - 2022-23.pdf
TheKredible's experts has summarized the Profit and Loss Statement of Symbio Generrics for FY 2022-23
₹249.00 ₹498.00
Balance sheet - Symbio Generrics - 2022-23.pdf
TheKredible's experts has summarized the Balance Sheet of Symbio Generrics for FY 2022-23
₹249.00 ₹498.00

AY - 2023-24

Profit and loss statement - Symbio Generrics - 2023-24.pdf
TheKredible's experts has summarized the Profit and Loss Statement of Symbio Generrics for FY 2023-24
₹249.00 ₹498.00
Balance sheet - Symbio Generrics - 2023-24.pdf
TheKredible's experts has summarized the Balance Sheet of Symbio Generrics for FY 2023-24
₹249.00 ₹498.00

Subscribe to our newsletter to stay updated